MAXHEALTH Q4 Results 2026 Preview: Date, Time, Expectations & Key Things To Watch

Max Healthcare enters its Q4 FY 2025-2026 earnings print following a period of strategic capacity expansion and the recent acquisition of Kalinga Hospital in Bhubaneswar. Investors will be looking for updates on the normalization of occupancy rates following recent cashless insurance service disruptions and the status of CGHS pricing revisions expected to impact FY27 profitability.

MAXHEALTH Q4 Results Date and Time

The board meeting is scheduled for May 21, 2026, to consider Q4 FY26 results and recommend final dividend for FY26.

What to expect from MAXHEALTH's Q4 FY26 results

In its most recently reported quarter, Max Healthcare posted revenue of Rs. 2,608 Crore, PAT of Rs. 344 Crore, and an EBITDA margin of 26.1%. Occupancy levels, which stood at 74% in Q3 FY26, are a primary focus for management as they work to recover from temporary cashless service disruptions that shifted the payor mix toward institutional patients (35.8% of bed share). The company is actively executing its capacity expansion plan to reach 8,000 beds by FY28, with the 400-bed Max Smart facility expected to contribute to the ramp-up following its Q3 FY26 infrastructure readiness. Management continues to emphasize EBITDA per bed as the core performance metric, anticipating that upward revisions to CGHS pricing will provide an estimated Rs. 150-160 Cr EBITDA benefit in FY27.

Key Things To Watch

Performance vs Guidance Tracking: Tracking progress against long-term capacity and financial targets.

• Bed Capacity — 8,000 beds by FY28 — On track with 9,844 bed pipeline by FY29
• CGHS Pricing Benefit — Rs. 150-160 Cr EBITDA addition in FY27 — Status of April 2026 tariff revision pending
• Net Debt-to-EBITDA — Below 1.0x — Currently below 1x

Strategic Execution and Capex: Updates on recent acquisitions and brownfield commissioning.

• Kalinga Hospital integration status and revenue contribution timeline following April 2026 acquisition
• Max Smart occupancy certificate status and initial patient traction
• Gurugram Sec-56 construction timeline and commissioning expectations

Operating Metric Trajectory: Monitoring normalization of key operational KPIs.

• Occupancy normalization from 74% level after Q3 seasonal softness and insurance disruptions
• ARPOB trajectory as new brownfield beds ramp up
• Max@Home and Max Lab growth sustainability following 23% and 13% YoY growth in Q3